Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients

Chan Mi Lee; Eunyoung Lee; Ji Hwan Bang; Sang Won Park; Wan Beom Park; Myoung Don Oh; Nam Joong Kim

doi:10.3947/ic.2021.0085

Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients

Chan Mi Lee, Eunyoung Lee, Ji Hwan Bang, Sang Won Park, Wan Beom Park, Myoung Don Oh, Nam Joong Kim

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).

Original language	English
Pages (from-to)	792-795
Number of pages	4
Journal	Infection and Chemotherapy
Volume	53
DOIs	https://doi.org/10.3947/ic.2021.0085
State	Published - Dec 2021

Bibliographical note

Publisher Copyright:
© 2021 by The Korean Society of Infectious Diseases,

Keywords

HIV
Prevalence
Tuberculosis
Tuberculosis, Multidrug-Resistant

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3947/ic.2021.0085

Cite this

@article{6f1195570c364a44b2779375b77d191f,

title = "Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients",

abstract = "Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).",

keywords = "HIV, Prevalence, Tuberculosis, Tuberculosis, Multidrug-Resistant",

author = "Lee, {Chan Mi} and Eunyoung Lee and Bang, {Ji Hwan} and Park, {Sang Won} and Park, {Wan Beom} and Oh, {Myoung Don} and Kim, {Nam Joong}",

note = "Publisher Copyright: {\textcopyright} 2021 by The Korean Society of Infectious Diseases,",

year = "2021",

month = dec,

doi = "10.3947/ic.2021.0085",

language = "English",

volume = "53",

pages = "792--795",

journal = "Infection and Chemotherapy",

issn = "2093-2340",

publisher = "Taehan Kamyom Hakhoe, Taehan Hwahak Yopop Hakhoe",

}

TY - JOUR

T1 - Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients

AU - Lee, Chan Mi

AU - Lee, Eunyoung

AU - Bang, Ji Hwan

AU - Park, Sang Won

AU - Park, Wan Beom

AU - Oh, Myoung Don

AU - Kim, Nam Joong

PY - 2021/12

Y1 - 2021/12

N2 - Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).

AB - Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).

KW - HIV

KW - Prevalence

KW - Tuberculosis

KW - Tuberculosis, Multidrug-Resistant

UR - http://www.scopus.com/inward/record.url?scp=85122672599&partnerID=8YFLogxK

U2 - 10.3947/ic.2021.0085

DO - 10.3947/ic.2021.0085

M3 - Article

AN - SCOPUS:85122672599

SN - 2093-2340

VL - 53

SP - 792

EP - 795

JO - Infection and Chemotherapy

JF - Infection and Chemotherapy

ER -

Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this